Individualization of Dosage of Irinotecan in the FOLFIRI According to the Genetic Polymorphism of UGT1A1 in the First Line Treatment of Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Irinotecan
Related studies linked through entity extraction aliases.
S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Metformin Plus Irinotecan for Refractory Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase I/II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan
- Status
- COMPLETED
- Phase
- PHASE2
Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Nordic 8 - A Phase II Trial
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase I/II Trial of Antagonism of HER in GI Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
GAMBIT Trial: Cisplatin Plus Irinotecan in the Treatment of Gallbladder or Biliary Tract Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI.
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis
- Status
- WITHDRAWN
- Phase
- NA